Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002222885 | SCV002500164 | likely benign | not specified | 2022-03-07 | criteria provided, single submitter | clinical testing | Variant summary: CYP27A1 c.69C>T alters a non-conserved nucleotide resulting in a synonymous change. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 6.5e-06 in 155006 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.69C>T in individuals affected with Cerebrotendinous Xanthomatosis and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely benign. |
Ambry Genetics | RCV002363723 | SCV002665429 | likely benign | Cardiovascular phenotype | 2021-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003434452 | SCV004151402 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | CYP27A1: BP4, BP7 |
Labcorp Genetics |
RCV003611568 | SCV004390726 | likely benign | Cholestanol storage disease | 2024-05-28 | criteria provided, single submitter | clinical testing |